EvidentIQ Germany tritt dem BVMA bei

Die EvidentIQ Germany GmbH – Teil der EvidentIQ Group und führender Anbieter von EDC-Software (Electronic Data Capture) für klinische Studien – ist ab sofort Mitglied im Bundesverband Medizinischer Auftragsinstitute e.V. […]

Weiterlesen

EvidentIQ Germany GmbH confirmed as a Platinum Pharma Supplier

EvidentIQ Germany was recognized as a Platinum Pharma Supplier by Qualifyze’s quality compliance program. This prestigious distinction acknowledges EvidentIQ Germany’s commitment to providing high-quality products and reliable services to the […]

Weiterlesen

10 Years of Successful Partnership between EvidentIQ Germany and Cardialysis in the Field of Clinical Studies

EvidentIQ Germany, formerly known as XClinical, a top provider of EDC software, is proud to mark a decade of fruitful collaboration with Cardialysis, a renowned CRO & Core Laboratory based […]

Weiterlesen

EvidentIQ is pleased to announce the addition of Asthenis GmbH to their comprehensive eClinical solutions group.

Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition of Asthenis GmbH, the market leader in cancer documentation software in the DACH region (Germany, […]

Weiterlesen

Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

EvidentIQ, the innovative provider of advanced clinical trial management solutions has joined forces with Quinta Analytica, a renowned GCP/GLP/GMP-certified European CRO and part of the Conscio Group. This collaboration aims […]

Weiterlesen